Causal analysis of absolute and relative risk reductions

Abstract excerpt

<p>Any medical innovation must first prove its benefits with reliable evidence from clinical trials. Evidence is commonly expressed using two metrics, summarizing treatment benefits based on either absolute risk reductions (ARRs) or relative risk reductions (RRRs). Both metrics are derived from the same data, but they implement conceptually distinct ideas. Here, we analyze these risk reductions measures from a cau...

Topics

Open a Topic to create a Post that cites this publication.

• Clinical Trials as Topic
• Confidence Intervals
• Evidence-Based Medicine
• Odds Ratio
• Protein Precursors
• Proteolipids
• Respiratory Distress Syndrome
• Risk Assessment

Identifiers and source

Literature Corpus work

b28fdd32-334d-5db2-bf9c-bb099d7d0a98

DOI

10.31234/osf.io/j98vt_v2